SARS-CoV-2 Humoral Immunity Persists Following Rituximab Therapy
10.3390/vaccines11121864
Saved in:
Main Authors: | Lu, Liangjian, Chan, Chang Yien, Lim, Yi Yang, Than, Mya, Teo, Sharon, Lau, YW, Ng, Kar Hui, Yap, Hui Kim |
---|---|
Other Authors: | PAEDIATRICS |
Format: | Article |
Published: |
Multidisciplinary Digital Publishing Institute (MDPI)
2023
|
Subjects: | |
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/246483 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Robust sars?cov?2 antibody responses in asian covid?naïve subjects 180 days after two doses of bnt162b2 mrna covid?19 vaccine
by: Lau, Chin-Shern, et al.
Published: (2022) -
Higher Delta variant-specific neutralizing antibodies prevented infection in close contacts vaccinated with ancestral mRNA vaccines during the SARS-CoV-2 Delta wave
by: Goh, Yun Shan, et al.
Published: (2024) -
Mechanistic insights of host cell fusion of SARS-CoV-1 and SARS-CoV-2 from atomic resolution structure and membrane dynamics
by: Chakraborty, Hirak, et al.
Published: (2021) -
Imprinting of IgA responses in previously infected individuals receiving bivalent mRNA vaccines (WT and BA.4/BA.5 or WT and BA.1)
by: Goh, Yun Shan, et al.
Published: (2024) -
The Effects of Heterologous Immunization with Prime-Boost COVID-19 Vaccination against SARS-CoV-2
by: Ho, Tzu-Chuan, et al.
Published: (2022)